Arq Q2 2026: Mixed Results Keep Wait Stance Intact

What happened

Arq reported mixed second-quarter 2026 results with a small revenue beat offset by weaker-than-expected profitability and persistently negative free cash flow. Management reiterated full-year guidance of $120-125 million in revenue and $17-20 million in Adjusted EBITDA, signaling a stable but unexciting outlook. The company is prioritizing its legacy powdered activated carbon (PAC) operations in the near term while keeping alive longer-term plans to enter the higher-margin granular activated carbon (GAC) market. This update aligns with prior concerns over execution risk, cash flow volatility, and the delayed GAC ramp, leaving the investment thesis largely unchanged. The stock remains a high-beta execution story with limited downside protection at current levels.

Implication

The Q2 results reinforce the need for patience; the modest top-line beat was overshadowed by weak profitability and negative free cash flow, which underscores the company's operational challenges. Reiterated guidance suggests management sees stability but no near-term inflection, and the transition to GAC remains behind schedule with an unproven moat. The balance sheet is still leveraged with thin interest coverage, limiting margin of safety. Positive catalysts would include tangible evidence of GAC ramp-up, a growing revenue mix toward water and remediation, and meaningful deleveraging. Until these materialize, the risk/reward for new positions is unattractive, and existing holders should focus on execution milestones rather than near-term earnings noise.

Thesis delta

The master report's WAIT stance is unchanged. The Q2 update does not alter key execution risks or the GAC timeline; it merely confirms that the business is not deteriorating rapidly but also not improving enough to warrant a more constructive view. The reiterated guidance provides modest reassurance but does not enhance the risk/reward profile.